Muscimol is dangerous, though the degree of danger depends heavily on dose, preparation, and what else is in your system. It is a potent psychoactive compound found in Amanita muscaria mushrooms that acts on the brain’s inhibitory signaling system. At low doses it produces sedation and altered perception; at higher doses it can cause seizures, coma, respiratory failure, and death. The FDA has explicitly stated that muscimol does not meet safety standards for use in food, and fatalities, while rare, are documented.
How Muscimol Affects the Brain
Muscimol mimics GABA, the brain’s main calming chemical, but it does so with far greater force. Across most receptor types, muscimol binds with roughly 100 to 1,000 times more affinity than GABA itself. On certain receptor subtypes found outside of normal signaling junctions in the brain, its binding affinity is extraordinarily high, activating those receptors at concentrations as low as 1 to 2 nanomoles. This means very small amounts of muscimol can produce significant neurological effects.
Because it floods the brain’s inhibitory system, muscimol produces a wide range of effects: euphoria, dizziness, heightened or distorted sensory perception, impaired coordination, and visual hallucinations. At higher doses, the same mechanism that creates sedation can suppress breathing and consciousness to dangerous levels.
Ibotenic Acid Makes Raw Mushrooms More Toxic
Amanita muscaria mushrooms contain both muscimol and its precursor, ibotenic acid. Ibotenic acid is a known neurotoxin that works through a completely different mechanism, overstimulating rather than calming nerve cells. When mushrooms are dried or heated, ibotenic acid converts into muscimol through a chemical process called decarboxylation. This reduces overall toxicity but does not eliminate it.
Eating raw or poorly prepared Amanita muscaria means ingesting both compounds simultaneously. Some research has linked repeated exposure to fungal neurotoxins like ibotenic acid to neurodegenerative conditions, though this connection is still being investigated. The critical point is that raw mushrooms pose a dual threat: the sedative danger of muscimol plus the excitatory neurotoxicity of ibotenic acid.
Lethal Dose and Fatality Risk
In mice, the lethal dose of muscimol (the amount that kills half the test animals) is 8.1 mg per kilogram of body weight. Notably, the dose where neurological toxicity begins is much lower, just 0.65 mg/kg. In rats, the oral lethal dose for muscimol is approximately 45 mg/kg. These numbers illustrate an important gap: you can experience serious neurological harm at doses well below what would kill you.
Human fatalities from Amanita muscaria poisoning are rare, occurring in an estimated 2% to 5% of reported cases. But they do happen. In one documented case, a 44-year-old man died after eating 6 to 10 dried Amanita muscaria mushrooms. He arrived at the emergency department in cardiac arrest and never recovered, dying after nine days on life support. Drug screening and autopsy found no other explanation for his death. In another case, a 75-year-old man required a breathing tube after eating a single mushroom cap but ultimately survived with hospital care.
Combining Muscimol With Other Substances
Mixing muscimol with alcohol, benzodiazepines, or any other substance that depresses the central nervous system is particularly dangerous. Research has shown that muscimol directly potentiates the sedative effects of alcohol. Both substances work on the same receptor system, so their effects don’t just add together; they amplify each other. This combination increases the risk of losing consciousness, stopping breathing, or both.
This interaction works in both directions. In lab studies, blocking the receptors muscimol acts on reduced the sedating and coordination-impairing effects of alcohol. The practical takeaway: if muscimol is in your system alongside any CNS depressant, the danger profile escalates sharply and unpredictably.
What Happens During a Poisoning
Muscimol poisoning typically presents as a confusing mix of symptoms. Patients may show signs of both overstimulation and sedation, including nausea, hallucinations, agitation, lethargy, and loss of coordination. In severe cases, this progresses to seizures, coma, and respiratory depression.
There is no antidote for muscimol poisoning. Treatment is entirely supportive: managing the airway, monitoring heart rhythm, and controlling agitation. Because the symptoms overlap with both cholinergic and anticholinergic poisoning, common reversal agents like atropine are actually contraindicated and can make things worse. Benzodiazepines may be used to control agitation, but they carry their own risk of compounding respiratory depression since they act on the same receptor family as muscimol. Severe cases may require intubation and mechanical ventilation.
FDA and Legal Status
The FDA issued a formal alert to food manufacturers stating that Amanita muscaria, its extracts, and its active constituents, including muscimol, are not authorized for use as ingredients in conventional food. The agency concluded that these ingredients do not meet the Generally Recognized As Safe (GRAS) standard and that their use in food products may be harmful. The FDA is also evaluating their use in dietary supplements.
Despite this, muscimol is not a controlled substance under U.S. federal law in the way that psilocybin or LSD are. This regulatory gap means products containing muscimol, often marketed as Amanita muscaria gummies or extracts, are sold commercially even though the FDA considers them unsafe as food ingredients. The lack of scheduling does not mean the compound is safe. It means enforcement has not caught up with the market.
Why Dosing Is Unpredictable
One of the most practical dangers of muscimol is the impossibility of consistent dosing from natural sources. The muscimol and ibotenic acid content in Amanita muscaria mushrooms varies enormously depending on the specimen’s age, growing conditions, part of the mushroom consumed, and how it was prepared. Two caps from the same patch of forest can contain vastly different amounts. Commercial products, particularly unregulated gummies and tinctures, may not accurately reflect their actual muscimol content.
Given that neurological toxicity in mice begins at just 0.65 mg/kg (which would translate to roughly 45 mg for a 150-pound person, though animal-to-human conversion is imprecise), the margin between a psychoactive dose and a medically dangerous one is not wide. Without reliable dosing information, every exposure carries a degree of unpredictable risk.